Ion Beam Applications SA
Ion Beam Applications SA (IOBCF) Financial Performance & Income Statement Overview
Analyze Ion Beam Applications SA (IOBCF) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
Ion Beam Applications SA (IOBCF) Income Statement & Financial Overview
View the income breakdown for Ion Beam Applications SA IOBCF across both annual and quarterly reports.
Metric | Q4 2024 | Q2 2024 | Q4 2023 | Q3 2023 |
---|---|---|---|---|
Revenue | $291.75M | $206.45M | $259.30M | $129.65M |
Cost of Revenue | $195.58M | $136.62M | $169.90M | $84.95M |
Gross Profit | $96.17M | $69.83M | $89.40M | $44.70M |
Gross Profit Ratio | $0.33 | $0.34 | $0.34 | $0.34 |
R&D Expenses | $31.07M | $26.93M | $23.72M | $13.55M |
SG&A Expenses | $47.84M | $42.87M | $38.97M | $19.48M |
Operating Expenses | $78.91M | $72.79M | $62.69M | $34.63M |
Total Costs & Expenses | -$274.49M | $209.41M | $232.59M | $119.58M |
Interest Income | $0.00 | $0.00 | $0.00 | $2.43M |
Interest Expense | $0.00 | $4.96M | $0.00 | $0.00 |
Depreciation & Amortization | $6.04M | $2.59M | $6.10M | $1.51M |
EBITDA | $24.004M | -$372000.00 | $15.06M | $15.66M |
EBITDA Ratio | $0.08 | -$0.002 | $0.13 | $0.12 |
Operating Income | $17.26M | -$2.96M | $26.71M | $14.15M |
Operating Income Ratio | $0.06 | -$0.01 | $0.10 | $0.11 |
Other Income/Expenses (Net) | $1.22M | -$3.86M | -$15.54M | -$2.98M |
Income Before Tax | $18.47M | -$6.82M | $20.29M | $11.17M |
Income Before Tax Ratio | $0.06 | -$0.03 | $0.08 | $0.09 |
Income Tax Expense | $2.12M | $3.48M | $4.19M | $2.09M |
Net Income | $19.60M | -$10.30M | $18.15M | $9.08M |
Net Income Ratio | $0.07 | -$0.05 | $0.07 | $0.07 |
EPS | $0.65 | -$0.35 | $0.62 | $0.31 |
Diluted EPS | $0.65 | -$0.35 | $0.62 | $0.31 |
Weighted Avg Shares Outstanding | $30.28M | $29.16M | $29.13M | $29.18M |
Weighted Avg Shares Outstanding (Diluted) | $30.28M | $29.16M | $29.13M | $29.18M |
The company's financials show resilient growth, with revenue advancing from $129.65M in Q3 2023 to $291.75M in Q4 2024. Gross profit remained healthy with margins at 33% in Q4 2024 compared to 34% in Q3 2023. Operating income hit $17.26M last quarter, sustaining a consistent 6% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at $24.004M. Net income rose to $19.60M, while earnings per share reached $0.65. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan